ABSTRACT
ity plays an important role in the pathogenesis of NAFLD. Th e IL-33/ST2 axis has a protective role in adiposity and atherosclerosis, but its role in obesity-associated metabolic disorders requires further clarifi cation. To investigate the unresolved role of IL-33/ST2 signalling in NAFLD, we used ST2-defi cient (ST2 -/-) and wild type (WT) BALB/c mice maintained on a high-fat diet (HFD) for 24 weeks. HFDfed ST2
- 
INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in developed countries and comprises a wide spectrum of liver pathologies, from benign liver steatosis to non-alcoholic steatohepatitis (NASH), eventually causing liver cirrhosis that may lead to hepatocellular carcinoma (1) . Approximately one third of the individuals with simple steatosis develop NASH, and among them, up to 20% will progress to liver cirrhosis over the period of years (2) .
NAFLD is considered as a hepatic manifestation of metabolic syndrome, which is a cluster of interrelated metabolic disorders, including obesity, hypertension and atherosclerosis, insulin resistance and diabetes, and dyslipidemia and fatty liver. The central features of metabolic syndrome are related to lipotoxicity, glucotoxicity and chronic low-grade inflammation leading to insulin resistance (3, 4) , for which immune mechanisms and complex cytokine network coordinate the inflammatory responses and metabolic disturbances (3, 5) . Genetic and environmental factors play a role in the development of obesity (6, 7) , but the cellular and molecular mechanisms involved in obesity-associated metabolic disorders are incompletely understood.
The hallmark of NAFLD is hepatocyte triglyceride accumulation. Hepatic steatosis represents excessive fat accumulation in hepatocytes and occurs as a result of multiple metabolic pathways, including increased fat delivery, increased fat synthesis, reduced fat oxidation, and/ or reduced fat export in the form of VLDL (8) . Increased circulating fatty acids (FFAs) and de novo lipogenesis from glucose are important determinants of hepatic steatosis. Adipose tissue dysfunction in obesity is thought to increase plasma FFAs, which are the major lipid providers in hepatic steatosis, and ectopic lipid accumulation in liver and muscle tissues, leading to insulin resistance. The mechanisms that lead to excessive plasma FFAs include increased lipolysis in adipose tissue, increased dietary fatty acids and newly synthesized fatty acids in the liver that are esterified into triglycerides and either stored in hepatocyte lipid droplets or secreted as plasma VLDLs (9) .
The molecular mechanisms involved in the progression of benign liver steatosis to liver inflammation and fibrosis in NA-FLD are incompletely understood. Hepatic lipid accumulation may promote the inflammatory response characterized by activated resident tissue macrophages (Kupffer cells), the increased infiltration of myeloid and lymphoid cells within the liver and the subsequent release of pro-inflammatory cytokines, including TNF-α, IL-6 and IL-1β, all of which enhance the progression of NASH to fibrosis. Moreover, the most recent study demonstrated that development of hepatic steatosis requires IL-1 signalling, which promotes hepatic lipogenesis (10) . Other members of the IL-1 superfamily, including the IL-1 receptor antagonist, IL-18 and IL-33, together with IL-1 have been implicated in various pathological conditions, but their roles in obesity-associated metabolic disorders are unclear.
IL-33 is a member of the IL-1 cytokine family, a multifunctional cytokine involved in the pathogenesis of various inflammatory and autoimmune diseases (11) . IL-33 is a pleiotropic cytokine that binds to its plasma membrane receptor complex comprising ST2 and the IL-1R accessory protein (11) and generally promotes Th2-type immune responses. IL-33 appears to exert protective metabolic effects in obesity and atherosclerosis (12) . IL-33 promotes liver fibrosis through the activation and expansion of liver-resident innate lymphoid cells, which produce profibrotic IL-13 (13) . In the fibrotic liver, IL-33 is present in activated hepatic stellate cells, which are key cellular mediators of liver fibrosis (14) .
The role of the IL-33/ST2 axis in obesity-associated metabolic disorders requires further clarification. We aimed to investigate the role of IL-33/ST2 signalling in the development of hepatic steatosis, inflammation and fibrosis in a model of high fat diet (HFD)-induced obesity using ST2-deficient (ST2 -/-) mice on the BALB/c background.
MATERIALS AND METHODS

Experimental mice and study design
Eight-week-old, male mice were used in the experiments. ST2-deficient mice (ST2 -/-mice) on the BALB/c background were generated by targeted disruption of the
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BSA -bovine serum albumin CD -cluster of differentiation CDNA -complementary DNA FCS -foetal calf serum FFAs -free fatty acids Gal-3 -galectin 3 HFD -high fat diet IFNγ -interferon-γ IL -Interleukin LXRα -Liver X receptor alpha NAFLD -non-alcoholic fatty liver disease NASH -non-alcoholic steatohepatitis PBS -phosphate-buffered saline PPARγ -peroxisome proliferator-activated receptor gamma qRT-PCR -quantitative real-time polymerase chain reaction RNA -Ribonucleic acid TNFα -tumour necrosis factor alpha VAT -visceral adipose tissue VLDL -very low density lipoprotein WT -wild type α-SMA -alpha smooth muscle actin mouse ST2 gene (15) . ST2 -/-mice were kindly provided by Dr McKenzie (University of Cambridge, UK). ST2-deficient (ST2-/-) and wild-type (WT) BALB/c mice were accommodated in our animal facilities under standard laboratory conditions in a temperature-controlled environment with a 12-h light/dark cycle. Mice received water and standard chow (10% calories from fat, Mucedola, Milano, Italy) or a high fat diet (60% calories from fat, Mucedola, Italy) ad libitum. Animals were sacrificed after 24 weeks of feeding, and blood samples and liver and visceral adipose tissues were collected for further analyses. All animal procedures were approved by the Ethical committee of the Faculty of Medical Sciences, University of Kragujevac.
Metabolic parameters
Body weights and fasting blood glucose levels were measured periodically, every 4 weeks. Before the measurements, mice were fasted for 4 h, and glucose levels (mmol/L) were determined using the Accu-Chek Performa glucometer (Roche Diagnostics, Mannheim, Germany). Serum concentrations of total cholesterol, triglycerides, AST and ALT were measured using the Olympus AU600 Chemistry Immuno Analyzer (Olympus, Tokyo, Japan). Fasting insulin levels in sera were measured using the Mouse Insulin ELISA Kit (Alpco, Salem, NH, USA).
Liver histological analysis
Livers were excised, fixed in 10% buffered formalin and embedded in paraffin. Tissue sections, 5-μm-thick, were stained with haematoxylin and eosin and picrosirius red as previously described (16) . The quantification of redstained collagen in liver sections stained with picrosirius red was performed on 10 fields of a section at 10X magnification, as previously described (17) .
We performed Oil Red O staining on 5-μm-thick liver tissue cryosections. Tissue sections were fixed in paraformaldehyde (10%), rinsed with 60% isopropanol and stained with freshly prepared a working solution of Oil Red O for 10 minutes. After rinsing with 60% isopropanol, sections were counterstained with Mayer's haematoxylin and mounted using water-based mounting medium. The quantification of red-stained lipids in mouse liver sections stained with Oil Red O was performed on 10 fields of a section at 100X magnification by digital image analyses, as previously described (18) .
The quantification of liver tissue inflammatory cell infiltration was performed in blinded fashion by two independent observers. Analysis was performed on 10 fields of a section at 10X magnification. Inflammatory cell infiltration was graded as follows: 0=no foci; 1=<2 foci/field; 2=2-4 foci per field; and 3=>4 foci per field. Then, a mean score was calculated (19) . Histological analysis was performed on tissue sections using light microscope (BX51; Olympus) equipped with a digital camera.
Immunohistochemistry
For immunohistochemical staining, we used paraffinembedded liver tissue sections (5-μm-thick). After performing heat-mediated antigen retrieval in citrate buffer (pH=6.0), deparaffinized tissue sections were incubated with primary mouse anti-α-SMA antibody (ab7817, Abcam, Cambridge, UK) or mouse anti-CD68 antibody (ab49777, Abcam). Staining was visualized using the Mouse-specific HRP/DAB Detection IHC Kit (ab64259, Abcam), and sections were counterstained with Mayer's haematoxylin. Sections were photomicrographed with a digital camera mounted on a light microscope (Olympus BX51, Japan), digitized and analysed. Analysis was performed on 10 fields of a section at 40X magnification. The results are presented as the mean count of positively stained cells per field.
Isolation of liver mononuclear cells
The mice were euthanized, and their livers were removed, thoroughly dissected and passed through a 100-μm nylon cell strainer (BD Biosciences); isolated cells were then suspended in complete RPMI-1640 medium containing 10% foetal calf serum (FCS). Cell suspensions were centrifuged at 507 rpm for 1 minute, and the supernatants enriched for mononuclear cells were collected and centrifuged at 1500 rpm for 10 minutes, as previously described (20) . Cell pellets were then resuspended in complete RP-MI-1640 medium.
Flow cytometry
Liver mononuclear cells were stained with combinations of either fluorochrome-labelled primary Abs or isotype controls for 30 min at 4°C. For intracellular staining, cells were activated with PMA/ionomycin and processed as previously described (21) . Cells were labelled with the following fluorochrome-conjugated monoclonal antibodies: anti-mouse CD3, CD11b, CD45, CD4, (BD Biosciences), F4/80, CD11c (BioLegend, San Diego, CA), and Ly-6C (Life Technologies, Carlsbad, CA). The cells were analysed using a FACSCalibur flow cytometer (BD Biosciences) and FlowJo software (Tree Star).
Expression of genes related to lipid metabolism and fibrosis in the liver
RNA was extracted from frozen mouse liver tissue using TRIzol (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Total RNA (2 μg) was reversetranscribed to cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, California, USA). qRT-PCR was performed using Power SYBR MasterMix (Applied Biosystems) and miRNA-specific primers for procollagen, αSMA, IL-33, CD36, IL-13, TGF-β, Abca-1, LXRα, and PPARγ as well as for β-actin, as a housekeeping gene (Table 1) . qPCR reactions were initiated with a 10-minute incubation time at 95°C followed by 40 cycles of 95°C for 15 seconds and 60°C for 60 seconds in a Mastercycler® ep realplex (Eppendorf, Hamburg, Germany). The fold change of miRNA gene expression was calculated by the equation 2 −ΔΔCt , described by Livak and Schmittgen (22) , where Ct is the cycle threshold. ΔCt was calculated by subtracting the Ct values of the endogenous control from the Ct values of the miRNA of interest. ΔΔCt was then calculated by subtracting ΔCt of the control from ΔCt of the calibrator.
Cytokine measurements
Cytokine levels in sera were measured using mouse Duoset ELISA kits for IL-6, IL-10, IL-13, IL-33, TGF-β, IFN-γ and TNF-α (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions.
Statistical analysis
Statistical analysis was performed using SPSS 22.0. Data are presented as the means ± SEM. Statistical significance was assessed by the Mann-Whitney U test, and, if appropriate, independent sample Student's t test. Statistical significance was assumed at p<0.05.
RESULTS
Metabolic analysis in WT and ST2
-/-BALB/c mice exposed to an HFD At the beginning of the experiment, WT and ST2 -/-BALB/c mice had similar body weights. After 24 weeks of feeding with either chow or an HFD, no differences in body weights were observed between WT and ST2 -/-mice. However, the weight gain and the weight gain expressed as a percentage of the initial body weight were significantly higher in ST2 -/-mice on an HFD compared with dietmatched WT mice (Fig. 1A) .
The visceral adipose tissue (VAT) weight and the VAT weight expressed as a percentage of total body weight were significantly higher in HFD-fed mice of both genotypes compared with chow-fed mice. The visceral adipose tissue weight was significantly higher in HFD-fed ST2 -/-mice compared with HFD-fed WT mice (Fig. 1A) . The liver weight and the liver weight expressed as a percentage of the total body weight were significantly lower in ST2 -/-mice on an HFD compared with HFD-fed WT mice (Fig. 1A) . Fasting blood glucose levels and the HbA1c percentage did not differ in HFD-fed mice of both genotypes, whereas fasting serum insulin levels were significantly lower in ST2 -/-mice compared with WT mice (Fig. 1B) .
Serum triglycerides were significantly higher in HFDfed ST2 -/-vs. WT mice as well as compared with chow-fed ST2 -/-mice. An HFD significantly increased total cholesterol serum levels in both genotypes, with no significant differences observed between ST2 -/-and WT mice (Fig.  1C) . ALT activity was significantly increased in HFD-fed WT and ST2 -/-mice compared with chow fed mice, with no differences found between the genotypes (Fig. 1D) . AST levels did not differ between chow-or HFD-fed ST2 -/-and WT mice.
Liver steatosis, inflammation and fibrosis in WT and ST2 -/-BALB/c mice
Semiquantitative analysis of lipid deposition in liver tissue sections stained with Oil Red O demonstrated that HFD increased liver steatosis in WT and ST2
-/-mice compared with chow-fed animals. However, liver steatosis was significantly lower in ST2 -/-mice on an HFD compared with diet-matched WT mice ( Fig. 2A) . Liver inflammation, as evaluated by the inflammatory cell infiltrate score, was significantly lower in ST2 -/-mice on an HFD compared with diet-matched WT mice (Fig. 2B) . The degree of liver fibrosis, quantified by staining collagen with picrosirius red, was significantly higher in both genotypes of mice fed an HFD compared with chow-fed mice. Notably, the degree of collagen deposition was significantly lower in HFD-fed ST2 -/-mice compared with HFD-fed WT mice (Fig. 2C ). Figure 1 . Metabolic parameters A. Body weight at the beginning of the experiment and after 24 weeks. Body weight gain as well as weight gain expressed as a percentage of the initial body weight were signifi cantly higher in ST2 -/-mice on a high-fat diet compared with diet-matched WT mice. Th e visceral adipose tissue weight and its weight expressed as a percentage of the total body weight were signifi cantly higher in high-fat diet-fed vs. chow-fed groups of mice of both genotypes. Th e visceral adipose tissue weight was signifi cantly higher in HFD-fed ST2 -/-mice compared with HFD-fed WT mice. Th e liver weight and the liver weight expressed as a percentage of the total body weight were signifi cantly lower in ST2 -/-mice fed an HFD compared with diet-matched WT mice. B. Th ere was no diff erence in fasting blood glucose levels between groups. Fasting serum insulin levels was signifi cantly lower in ST2 -/-mice compared with WT mice, both fed an HFD. C. Total cholesterol levels in the sera were signifi cantly higher in the HFD-fed groups compared with the respective chow diet-fed groups. ST2 -/-mice fed an HFD had signifi cantly higher levels of serum triglycerides compared with ST2 -/-as well as WT mice fed a chow diet. D. ALT activity was signifi cantly increased in WT and ST2 -/-mice fed an HFD compared with the respective chow-fed groups. Th ere were no diff erences in AST activity between groups.
Figure 2. Liver steatosis, infl ammation and fi brosis
A. Signifi cantly higher liver steatosis was observed in WT mice fed an HFD compared with WT mice fed chow. Signifi cantly higher liver steatosis was observed in ST2 -/-mice fed an HFD compared with ST2 -/-mice fed chow. Liver steatosis was signifi cantly lower in ST2 -/-mice than in WT mice, both fed an HFD. B. Liver infl ammation, as evaluated by the infl ammatory cell infi ltrate score, was signifi cantly lower in HFD-fed ST2 -/-mice compared with HFD-fed WT mice. C. Th e degree of liver fi brosis was signifi cantly higher in mice fed an HFD compared with mice fed a chow diet in both genotypes. Th e extent of liver fi brosis was signifi cantly lower in ST2 -/-mice fed an HFD compared with diet-matched WT mice.
HFD significantly increased the number of CD68 + macrophages in livers in WT and ST2 -/-mice. However, the number of CD68 + macrophages was significantly lower in chow-or HFD-fed ST2 -/-mice compared with diet-matched WT mice (Fig 3A) . HFD feeding significantly increased the number of αSMA-positive myofibroblasts in the livers of ST2 -/-mice only; there was no difference in the number of αSMA-positive cells between the two genotypes of mice fed chow or an HFD (Fig. 3B) .
Immune cell composition in the livers of WT and ST2 -/-BALB/c mice
We analysed several populations of innate immune cell and lymphocyte subpopulations. HFD feeding increased the percentage of F4/80 + macrophages in the livers of WT mice; in contrast, no significant differences in the proportion of these cells were found between WT and ST2 -/-mice on an HFD. The percentage of CD11c + F4/80 -dendritic cells (DCs) was significantly higher in both genotypes fed an HFD compared with chow-fed mice. CD11c + DCs were significantly lower in the livers of ST2 -/-mice fed either chow or an HFD compared with diet-matched WT mice (Fig. 4A) .
HFD feeding significantly increased the percentage of CD11b + Ly6C low cells in WT mice compared with HFD-fed ST2 -/-mice. In contrast, HFD increased the percentages of CD11b + Ly6C high cells in both genotypes, and the proportion of these cells was significantly higher in both chowand HFD-fed ST2 -/-mice compared with diet-matched WT mice (Fig. 4B) . 
Among gated CD4
+ T cells, no difference in the percentage of IFN-γ producing cells was observed among the genotypes of mice fed either chow or an HFD. However, the percentage of IL-17-producing CD4 + T cells was significantly lower in HFD-fed ST2 -/-mice compared with HFD-fed WT mice (Fig. 4C) .
The expression of genes related to liver lipid metabolism and fibrosis and cytokine profiles in the sera of WT and ST2 -/-BALB/c mice HFD significantly increased the expression of ATP binding cassette sub-family A member 1 (Abca-1), CD36 and oxysterol receptor LXR-alpha (LXR-α) genes in the livers of WT mice compared with chow-fed animals; no differences were observed in the mRNA levels of peroxisome proliferator-activated receptor gamma (PPAR-γ) (Fig. 5A ). LXRα and PPAR-γ expression was significantly lower in HFD-fed ST2 -/-mice compared with diet-matched WT mice.
HFD significantly increased expression of the liver fibrosis-related genes collagen alpha 1 chain precursor (procollagen), and alpha smooth muscle actin (αSMA) and the profibrotic genes IL-33 and IL-13 in the livers of WT mice compared with chow-fed animals (Fig 5B) . In ST2 -/-mice, HFD feeding led to significantly increased αSMA expression. The expression of procollagen, IL-33 and IL-13 was significantly lower in ST2 -/-vs. WT mice, both fed an HFD. TGF-β precursor expression was not influenced by HFD feeding in both genotypes, although its expression was significantly higher in chow-fed ST2 -/-mice compared with diet-matched WT mice (Fig. 5B) .
We also analysed serum proinflammatory and profibrotic cytokine levels in WT and ST2 -/-mice fed to an HFD for 24 weeks, as indicated in Figure 5 . The levels of TNF-α, IL-13 and IL-33 were significantly lower in the sera of ST2 -/-mice compared with WT mice (Fig. 5C ).
DISCUSSION
Mice on a BALB/c background are relatively resistant to HFD-induced obesity (23) . However, we demonstrate that HFD-fed ST2-deficient mice had significantly higher body weight gain compared with wild type mice. It appears that ST2 deletion may partially attenuate the resistance to diet-induced obesity. This result is in accordance with previous studies, which suggested that In line with these studies (12, 24) we also demonstrate the higher amount of visceral adipose tissue in ST2 -/-mice maintained on an HFD. Our main objective in this study was to investigate the unresolved role of the IL-33/ST2 axis in the development of hepatic steatosis. We demonstrate here that HFD-induced steatosis was ameliorated in ST2 -/-mice compared with wild-type mice. Furthermore, the extent of liver steatosis was also significantly lower in ST2 -/-mice on a standard diet compared with diet-matched WT mice. The lack of IL-33/ST2 signalling resulted in increased visceral fat weight and hypertriglyceridemia and attenuated liver steatosis in mice fed an HFD. This finding was somewhat unexpected consider-ing that enhanced lipolysis in enlarged adipose tissues in obesity was shown to be the main contributing factor in the development of liver steatosis (9, 25) . Adipose tissue lipolysis is the catabolic process leading to the breakdown of triglycerides stored in fat cells and the release of fatty acids and glycerol (26) . Our findings imply that the protective effect of IL-33 in the obesity-associated enlargement of visceral adipose tissue is not exerted on hepatic steatosis. The role of IL-33/ST2 signalling in hepatic steatosis has not been investigated. Recent report suggests that IL-33/ST2 expression may promote maternal lipolysis during pregnancy (27) . It could be speculated that the discrepancy between the protective effects on HFD-induced adiposity and enhanced liver steatosis may be related to the presumption that IL-33 promotes lipolysis and the "relocation" of fatty acids in the liver. Furthermore, we demonstrated that WT mice fed an HFD have increased expression of genes associated with lipid metabolism in the liver. The expression of fatty acid translocase (CD36/FAT) was significantly higher in WT mice than in ST2 -/-mice, both fed an HFD. When fatty acids are released from adipose tissue stores, they enter the circulation as FFAs. CD36 is a molecule involved in the uptake of fatty acids by cells (28) . We show markedly lower LXRα expression in HFD-fed ST2 -/-mice compared with HFD-fed WT mice. Liver X receptor alpha (LXRα) is oxysterol-activated nuclear receptor that is expressed in the liver and in other tissues and that regulates inflammation and lipogenesis. It has been demonstrated that LXRα activation has potentially deleterious effects by promoting hepatic steatosis and insulin resistance (29, 30) . As opposed to ST2 -/-mice, WT mice fed an HFD had increased expression of peroxisome proliferator-activated receptor (PPARγ), which has been associated with exacerbated steatosis when overexpressed in hepatocytes (31) .
Our findings point to an important role for IL-33/ ST2 signalling in obesity-associated changes in lipid metabolism in the liver. A recent study showed that the development of hepatic steatosis requires IL-1 signalling (10) , and considering that the IL-33/ST2 axis shares similar downstream molecules with the IL-1 pathway, IL-33/ST2 signalling should be further explored in hepatic lipogenesis. Recently, the direct role of IL-17 in liver steatosis and fibrosis has been demonstrated (32, 33) . In accordance with this finding, we showed that IL-17-producing CD4 + cells were less numerous in the livers of HFD-fed ST2 -/-mice compared with diet-matched WT mice. Liver inflammation was attenuated in ST2 -/-mice fed an HFD, as evaluated by lower inflammatory scores and lower numbers of CD68 + macrophages and percentages of CD11c + DCs in the livers of these mice compared with diet-matched WT mice. Liver damage due to pronounced steatosis in WT mice has been coupled with on-going fibrosis. In contrast to HFD-fed ST2 -/-mice, higher gene expression of procollagen, IL-33 and profibrotic IL-13 observed in the livers of HFD-fed WT mice supports the notion of the profibrotic role of IL-33/ ST2 signalling in the liver. This was accompanied by increased collagen deposition in steatotic livers of HFD-fed WT mice and increased sera levels of IL-33 and IL-13.
In addition, we also demonstrated that CD11b+Ly6c low monocytes, which are cells with profibrotic or M2-type functions in the liver (34, 35, 36) , were more numerous in the livers of HFD-fed WT mice compared with dietmatched ST2 -/-mice.
Conclusion
In summary, our findings are compatible with the notion that the IL-33/ST2 (IL-33R) axis may play multiple roles in obesity-associated metabolic disorders and NA-FLD. IL-33/ST2 signalling attenuates adiposity and inflammation in visceral adipose tissue but promotes liver steatosis, inflammation and fibrosis, most likely by modulating cell trafficking and the metabolic pathways that link adipose and liver tissues in obesity.
